B

BlueLight Therapeutics, Inc.

50 employees

BlueLight Therapeutics uses a proprietary structure-based platform to discover small molecules against difficult-to-drug targets.

Basic info

Industry

biotechnology research

Sectors

Proteins
Biotechnology
Health Care
drug discovery
Conformational Change
Therapeutics
Instrumentation
Medical

Date founded

2013

Funding rounds raised

Total raised

$20M

from 3 investors over 3 rounds

B

BlueLight Therapeutics, Inc. raised $20M on September 10, 2018

Investors: 5AM Ventures

B

BlueLight Therapeutics, Inc. raised $10M on January 21, 2016

Investors: 5AM Ventures

B

BlueLight Therapeutics, Inc. raised $15M on October 17, 2013

Investors: 5AM Ventures

FAQ